Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 4;14(5):e24716.
doi: 10.7759/cureus.24716. eCollection 2022 May.

Eosinophilic Vacuolated Tumor of Kidney: Clinical Perspective of a New Pathologic Emerging Entity

Affiliations
Case Reports

Eosinophilic Vacuolated Tumor of Kidney: Clinical Perspective of a New Pathologic Emerging Entity

İbrahim Kartal et al. Cureus. .

Abstract

The eosinophilic vacuolated tumor (EVT) of the kidney is a newly identified and pathological emerging entity. In this case report, EVT diagnosed due to a partial nephrectomy performed for a suspicious kidney mass in a 47-year-old patient is presented. A review of the literature and this case indicates that EVT, also called high-grade oncocytoma, does not show clinically aggressive behavior. However, in case of clinical suspicion, tumors with this oncocytic morphology should be treated with nephron-sparing treatment methods, considering that they may be hybrid malignancies.

Keywords: eosinophilic; hybrid malignancy; kidney; nephron-sparing treatment; oncocytoma; vacuolated tumor.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Eeosinophilic vacuolated tumor in a 47-year-old man
A-B: Computed tomography transverse and coronal sections showing well-defined round heterogenous enhancement of the left lower pole renal mass (white arrows); C. Coronal contrast-enhanced T1-weighted image shows heterogeneous enhancement in the left lower pole renal mass (white arrow).
Figure 2
Figure 2. A. Tumor shows a solid growth pattern with large thick-walled vessels and entrapped non-neoplastic tubules at the periphery (hematoxylin and eosin x100). B. Tumor cells exhibit voluminous eosinophilic cytoplasm with prominent intracytoplasmic vacuoles. The cells have round nuclei and prominent nucleoli (hematoxylin and eosinx200). C. Tumor cells are positive for CD117 (x100). D. CK7 is negative in tumor cells. Only entrapped non-neoplastic tubules are positive for CK7 (x100).

References

    1. Renal oncocytoma: an algorithm for diagnosis and management. Abdessater M, Kanbar A, Comperat E, Dupont-Athenor A, Alechinsky L, Mouton M, Sebe P. Urology. 2020;143:173–180. - PubMed
    1. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Trpkov K, Williamson SR, Gill AJ, et al. Mod Pathol. 2021;34:1167–1184. - PubMed
    1. "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases. He H, Trpkov K, Martinek P, et al. Virchows Arch. 2018;473:725–738. - PubMed
    1. Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm. Chen YB, Mirsadraei L, Jayakumaran G, et al. Am J Surg Pathol. 2019;43:121–131. - PMC - PubMed
    1. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. Farcaş M, Gatalica Z, Trpkov K, et al. Mod Pathol. 2022;35:344–351. - PubMed

Publication types

LinkOut - more resources